Evidence map›Paper›PMID 32154056›Full record

ArticleJIMD reports2020

The c.1A > C start codon mutation in

Willemijn F E Kuper, Claudia van Alfen, Linda van Eck, Stella A de Man, Marjolein H Willemsen, Koen L I van Gassen, Monique Losekoot, Peter M van Hasselt

Open access · goldAbstract readCase Reports
In one paragraph

Article in JIMD reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Willemijn F E KuperDepartment of Metabolic Diseases, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.ORCID https://orcid.org/0000-0003-1676-6759
Claudia van AlfenBartiméus Institute for the Visually Impaired Zeist, Doorn The Netherlands.
Linda van EckBartiméus Institute for the Visually Impaired Zeist, Doorn The Netherlands.
Stella A de ManDepartment of Pediatrics Amphia Hospital Breda The Netherlands.
Marjolein H WillemsenDepartment of Human Genetics Radboud University Medical Center Nijmegen The Netherlands.
Koen L I van GassenDepartment of Genetics University Medical Center Utrecht Utrecht The Netherlands.
Monique LosekootDepartment of Clinical Genetics Leiden University Medical Center Leiden The Netherlands.
Peter M van HasseltDepartment of Metabolic Diseases, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University Utrecht The Netherlands.
Bartiméus · NLUtrecht University · NLAmphia Ziekenhuis · NLLeiden University Medical Center · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCLN3 disease is a disorder of lysosomal homeostasis predominantly affecting the retina and the brain. The severity of the underlying mutations in CASE SERIES: We present three patients with an identical

conclusionsContrasting our initial expectations, patients with a start codon variant in

Indexed as

CLN3counselingprotracted phenotypestart codontranslation initiation codon

Identifiers

PMID32154056
PMCPMC7052694
OpenAlexW3005230331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.